GLI2 and ovarian serous adenocarcinoma: Representatively, the relative gene expression levels of HH pathway genes in 16 primary grade 3 serous ovarian cancer samples standardized against normal ovarian cell lines demonstrated higher GLI2 levels only in 25% of the samples [16].